Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by ARTLETT, C. M.
Right arrow Articles by WELSH, K. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by ARTLETT, C. M.
Right arrow Articles by WELSH, K. I.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1996 British Society for Rheumatology

other

DNA ALLELIC ALTERATIONS WITHIN VNTR LOCI OF SCLERODERMA FAMILIES

C. M. ARTLETT, C. M. BLACK*, D. C. BRIGGS{dagger}, C. STEPHENS{dagger} and K. I. WELSH

Tissue Typing, Oxford Transplant Centre, Churchill Hospital Oxford
*Rheumatology, Royal Free Hospital London
{dagger}Tissue Typing, Middlesex Hospital London

Correspondence to: Correspondence to: C. Artlett, Department of Rheumatology, Rm 522 BLSB, Thomas Jefferson University, Philadelphia, PA 19107, USA

We have characterized genetic alterations at the molecular level in 49 scleroderma and 45 control families using variable number tandem repeats (VNTRs). Additionally, paired fibroblast cell lines from the ‘affected’ and ‘unaffected" skin and peripheral blood leucocytes of 30 patients were also examined. All families in this study were typed for Class I Cw alleles and Class II-DRB, -DQA and -DQB to confirm family membership. There were significant rises in the level of VNTR mutations in scleroderma patients (36.7%, n = 18), their siblings (16.3%, n = 13) and offspring (21.7%, n = 15). The level of VNTR mutations in the control group was 0.6% (n = 5). These mutations did not correlate with the presence of autoantibodies and no patient was taking a known clastogenic drug. The most common VNTR site for mutation was pYNZ22 (17pl3.4). Differences were also seen in the VNTR alleles between fibroblast and lymphocyte DNA from the same patient, as measured by size alteration of one of the alleles. We have found that VNTRs are unstable in scleroderma patients, relatives and offspring. The reason for the genomic changes remains unknown, but previous studies have implicated the presence of a clastogen.

KEY WORDS: Scleroderma, VNTR, Chromosomal instability


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Ann Rheum DisHome page
C L Hill, A-M Nguyen, D Roder, and P Roberts-Thomson
Risk of cancer in patients with scleroderma: a population based cohort study
Ann Rheum Dis, August 1, 2003; 62(8): 728 - 731.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.